Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > $12 target

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Mar 21, 2022 12:24pm

274 Views

Post# 34531620

RE: RE:RE:$12 target

knoxt wrote

I will sell all my holding at $12.00 and you will never hear from again . Live a rich live .

Cheers

Hi knoxt you appear to be a savvy investor, as your future target approaches please assess current objectives of this company at that time. Sell if you wish however selling up to 50% if other indications are at that time looking successful might be more strategic. Bottom line is NMIBC could be worth $50 - $100 a share, therapeutic/vaccine could be worth $50 - $150 a share GBM $30 a share NSCLC $100 - $200 a share!
You know best what your personal situations are as in health & age, thing is we like having you around.

<< Previous

Bullboard Posts

Next >>

Bitcoin company adds convenience of modern banking